Post Pandemic Obesity Posing a New Challenge

Translate to Spanish or other 102 languages!

Nearly two years into fighting COVID-19, we may have learned how to build our immunity but experts say we have unmasked another killer, obesity.  Newswise Image
Nearly two years into fighting COVID-19, we may have learned how to build our immunity but experts say we have unmasked another killer, obesity.  Newswise Image

Mega Doctor News

- Advertisement -

by Hackensack Meridian Health

Nearly two years into fighting COVID-19, we may have learned how to build our immunity but experts say we have unmasked another killer, obesity. 

“With so many people working from home and living a much more sedentary lifestyle, obesity has been steadily on the rise, “said Hans Schmidt, MD, chief, Bariatric Surgery at Hackensack University Medical Center. 

- Advertisement -

In fact, new data from the Centers for Disease Control and Prevention showed 16 states now have obesity rates of 35% or higher. That’s an increase of four states — Delaware, Iowa, Ohio and Texas — in just one year.

“Obesity is a leading risk factor for almost every serious disease from diabetes and heart disease to cancer and even COVID-19,” explained Dr. Schmidt. 

So, it may come as no surprise that interest in bariatric surgery is also on the rise. “At one point during the pandemic, it was estimated that 78% of hospitalized COVID-19 patients were obese or overweight and this had a major impact, people realized there was a correlation and were afraid,” explained Dr. Schmidt.

Emerging research may now explain why. A new, non-peer reviewed study found that COVID-19 may infect fat cells directly. The news may suggest that overweight and obese people may be at increased risk for severe disease and long COVID.

- Advertisement -

Today, Dr. Schmidt’s office is seeing a rise in people interested in learning more about weight loss options, including bariatric surgery. 

Beyond weight loss, new studies show bariatric surgery boosts life expectancy, reduces pressure inside the skull, lowers the risk of liver disease, COVID-19  and is effective at improving vascular outcomes.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Robotic Surgery Program Expanded at STHS McAllen

From smaller incisions and less pain to shorter hospital stays and faster recovery times, robotic-assisted surgery is changing the way patients experience surgical care.

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen. FULL TO CAPACITY. NO MORE ROOM.

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

Highway Crash Leads to Unexpected STC Connection

What began as a flat tire on the side of a highway turned into a frightening collision and an unexpected encounter for South Texas College faculty member Jesus Amaya, when the paramedic who responded to the scene turned out to be one of STC’s graduates.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.
- Advertisement -